Opinion on Healthcare in Asia-Pacific

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Celiac disease: improved diagnosis potential highlights untapped market

A new study has highlighted the benefit of routine antibody testing in suspected cases of celiac disease. While these data prove the merit of serological testing, awareness of the disease remains a significant issue. Indeed, with almost no treatment options available, the development of an effective pharmacological therapy offers the potential to reap significant returns from this untapped market.

Published By Datamonitor
21 Dec 2009
Expert View
Expert View

Clinical decision support tools set to fundamentally change the way medicine is practiced

Clinical decision support tools, technologies that provide information to aid the diagnosis and treatment of patients, are set to make dramatic changes to the practice of medicine, according to a new report by Datamonitor. However, the report also predicts that aspects of medical culture will prove barriers to adoption.

Published By Datamonitor
24 Jul 2008
Expert View
Expert View

Drug reps must embrace technology to avoid missing sales opportunities

In a pharmaceutical market where the days of the primary care blockbuster-selling drug appear numbered, the days of pharma sales representatives having time to visit physicians with drug samples are also waning. Reps must now embrace internet technology to ensure samples are efficiently distributed to physicians and also take on the role of educators in their dynamic relationships with physicians.

Published By Datamonitor
15 Mar 2006
Expert View
Expert View

Electronic health records: crucial for a modern healthcare system

Despite the bad publicity surrounding the implementation of electronic health records in some cases, effectively managing patient information will be key to the modernization of today's healthcare systems. Datamonitor expects the overall global electronic health records market to grow to almost $13 billion by 2012 - a compound annual growth rate of 23.8%.

Published By Datamonitor
10 Jan 2008
Expert View
Expert View

Google is well positioned to enter the personal health record market

Datamonitor believes that, through its brand strength, Google's entry into the personal health record market is likely to make personal health records a success and result in consumers becoming more knowledgeable about their health. While other companies have developed personal health records, the significance of Google's entry cannot be underestimated due to its unparalleled consumer reach.

Published By Datamonitor
06 Mar 2008
Expert View
Expert View

Immunization against S. aureus has potential in selected target groups

Staphylococcus aureus bacteria have become a key concern in both the hospital and community setting. The spread of resistant strains, such as MRSA, underlines the urgent need for new strategies to treat and prevent these infections. Prophylactic vaccination of target groups could be a useful tool, but prudent group selection combined with alternative prevention strategies, will be key to success.

Published By Datamonitor
17 Jul 2008
Expert View
Expert View

Is telemedicine worth the money

Published By Datamonitor
13 Jul 2001
ResearchWire
ResearchWire

Leukemia: US has highest rate of non-specialist diagnosis

Published By Datamonitor
23 May 2001
Expert View
Expert View

Personal health records will play an important role in the exchange of health information

Early successes in healthcare interoperability are paving the way for more health information exchanges in the near to mid future. Separate networks, including personal health records, will connect to form larger networks, and despite continuing skepticism surrounding the burgeoning technology, health information exchanges look set to become a typical part of the patient experience.

Published By Datamonitor
13 Nov 2008
Expert View
Expert View

Pharmaceutical product lifecycle management technology gaining momentum

Growing regulatory pressure and competition from generics will drive adoption of product lifecycle management software and services in the pharmaceutical industry. Datamonitor estimates spending on product lifecycle management software by the pharmaceutical industry in Europe, North America, China and Japan to total $460.2 million by the end of 2007 and expects this to more than double by 2012.

Published By Datamonitor
21 Sep 2007

« | 1 | 2 | » »|

No help is available.